Found: 7
Select item for more details and to access through your institution.
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22875-w
- By:
- Publication type:
- Article
3-Substituted Indazoles as Configurationally Locked 4EGI-1 Mimetics and Inhibitors of the eIF4E/eIF4G Interaction.
- Published in:
- ChemBioChem, 2014, v. 15, n. 4, p. 595, doi. 10.1002/cbic.201300723
- By:
- Publication type:
- Article
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1161869
- By:
- Publication type:
- Article
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
- Published in:
- Nature Communications, 2014, v. 5, n. 10, p. 5241, doi. 10.1038/ncomms6241
- By:
- Publication type:
- Article
Chemical genetics identify eIF2? kinase heme-regulated inhibitor as an anticancer target.
- Published in:
- Nature Chemical Biology, 2011, v. 7, n. 9, p. 610, doi. 10.1038/nchembio.613
- By:
- Publication type:
- Article
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8<sup>+</sup> T cell exhaustion.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18298-8
- By:
- Publication type:
- Article
Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway.
- Published in:
- Oncology Reports, 2015, v. 34, n. 4, p. 1787, doi. 10.3892/or.2015.4143
- By:
- Publication type:
- Article